Miles Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Miles Capital’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$520K	Sell	6,717 -33	-0.5%	-$2.92K	0.56%	50
2019 Q4	$642K	Sell	6,750 -419	-6%	-$36.2K	0.52%	55
2019 Q3	$547K	Sell	7,169 -6	-0.1%	-$499	0.45%	63
2019 Q2	$629K	Buy	7,175 +462	+7%	+$39.4K	0.51%	60
2019 Q1	$608K	Sell	6,713 -297	-4%	-$25.3K	0.53%	60
2018 Q4	$503K	Buy	7,010 +260	+4%	+$20.9K	0.5%	62
2018 Q3	$647K	Buy	6,750 +1,152	+21%	+$112K	0.52%	56
2018 Q2	$533K	Sell	5,598 -4,318	-44%	-$397K	0.33%	62
2018 Q1	$870K	Buy	9,916 +383	+4%	+$35K	0.48%	50
2017 Q4	$809K	Buy	+9,533	New	+$799K	0.47%	52

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return

Miles Capital's XBI Position: Q1 2020 in Review

Miles Capital reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 0.49% in Q1 2020, selling an estimated $2.92K and leaving 6,717 shares worth $520K. The position accounts for 0.56% of the portfolio, ranked #50.

Miles Capital first reported a position in XBI in Q4 2017 and has held it in 10 quarters since. The position peaked at $870K in Q1 2018. 458 funds tracked by Wall St. Rank hold XBI as of Q1 2020.

Miles Capital held 6,717 shares of State Street SPDR S&P Biotech ETF worth $520K as of Q1 2020.
Miles Capital sold 33 State Street SPDR S&P Biotech ETF shares in Q1 2020, an estimated $2.92K.
State Street SPDR S&P Biotech ETF made up 0.56% of Miles Capital's portfolio in Q1 2020, its #50 holding.
Miles Capital first reported a position in State Street SPDR S&P Biotech ETF in Q4 2017 and has held it in 10 quarters since.
Miles Capital's State Street SPDR S&P Biotech ETF position peaked at $870K in Q1 2018.
458 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2020.

Based on Miles Capital's 13F filing for Q1 2020, filed 13 May 2020.